becoming more unstable with increasing pH. In fact compound2 at pH10 has been shown to rearrange to 3 via an intramolecular transacylation. 1 1' In this paper we describe acylation of the amine group of 4 and 5 to decrease its basicity/ nucleophilicity, and in turn increase their chemical stability.
The mono-and dipeptide derivatives are shown to be useful as prodrugs in vivo. Also, a jS-chloroalanine dipeptide conjugate is conceived monopeptide by reacting it with the NCAunder the same reaction conditions. In order to prevent the formation of the "over reaction" product 10, the reaction was carried out with an alternative acylating species, 17 obtained by the addition of a stoichoiometric amount of DMAP to a solution of 6 in dioxane. Also, using 17 the monopeptide 9 was cleanly converted to the dipeptide 10. It is noteworthy that the reaction time was relatively longer in the formation of 15 and 16 from 5 and 8, which may be attributed to the tendency of the longer methylene chain (n = 4) to fold in aqueous mediumthus making the amino group less frequently exposed for reaction.
Results and Discussion As anticipated, the chemical stability of 4 (Ti/2 = 3.8 hours) was dramatically improved in the 7V-acetyl derivative 18 (T1/2=73hours, Table 1 ), althought its in vitro and in vivo antibacterial activities, especially against Pseudomonas aeruginosa were drastically diminished. Similar behavior was exhibited by the 7V-(2-aminoethyl) acyl (19) and the iV-(2-hydroxyethyl) acyl (20) derivatives (Table 1) . In order to restore the antibacterial activities, particularly in vivo, while retaining the highly desirable acylation effect on increased chemical stability, the acyl moiety was chosen as an ammoacid or its derivative. In such derivatives the amide bond becomesa peptide bond, which may then be cleaved in vivo by non-specific peptidases with release of the parent amine, the /Mactam (4). The mono-and dipeptide derivatives of the natural amino acids L-glycine (21), L-alanine (ll, 12) and a derivative of the latter, the /?-chloro-L-alanine (13, 14) showed greater chemical stability and similar or even better in vivo (PD50) antibacterial activities than the parent amine (4) ( Table 2 ). The much higher PD50 values (Table 2 ) of the unnatural D-alanine derivatives (9, 10) suggest that the peptide bond was not recognized, and hence not cleaved by peptidases, thus making them behave more like simple 7V-acyl JAN. 1993 Microdilution method using Mueller-Hinton broth. Streptococci were tested using Todd-Hewitt broth.
In mg/kg per dose in mice.
Half-life in a 10~4m pH 7.4 phosphate buffer solution at 37°C in hours. For full names, see Table 1 .
derivatives (18, 19, 20) . From the excellent PD50 values of the natural L-peptide conjugates of the /Mactam 4, it is apparent that they act as prodrugs by the cleavage of the peptide bonds by some internal hydrolytic mechanismeither before or within the periplasmic space liberating the /Mactamand the peptide moieties, the former expressing its antibacterial action by binding to penicillin binding proteins on the surface of the cytoplasmic membrane. Based on this, it was reasoned that if the liberated peptide moiety, instead of being wasted, might be utilized to augment the antibacterial action of the /Mactam, in which case the peptide conjugate might be viewed as a "dual-action" antibiotic with possible synergistic effect. In this context it may be mentioned that /?-chloro-L-alanine (BCLA)inhibits alanine racemase, 14' 1 5) a cytoplasmic enzyme involved in peptidoglycan synthesis, which is also the ultimate target for /Mactamantibiotic action. Hence, the BCLAdipeptide derivative (14) was synthesized with the anticipation that the liberated dipeptide might actively be transported by peptide permeases into the bacterial cell where it would be cleaved by peptidases to BCLA. It may be emphasized that the antibacterial action of BCLA is restricted to
Gram-positive strains.14'15) Hence, it is pertinent to compare PD50 values of the amine 4 and the BCLA dipeptide conjugate 14 only against Staphylococcus aureus in order to assess the synergism. It wasgratifying to note that the BCLAdipeptide 14 in vivo was ca. 3 times more active than the parent amine 4 against this organism ( Table 2 ). The low level of synergism was attributed to a very low intracellular concentration of the inhibitor (BCLA)as a consequence of indiscriminate extracellular cleavage of both the peptide bonds linking the /Mactam moiety (4), thus prematurely liberating the inhibitor (BCLA) as a monomer which could not be transported into the cell. S. aureus was similar to that of the parent 4, in accordance with this contention. It may be commentedthat a change in charge characteristics from one positive and one negative (zwitterionic) in 4 to a single negative charge in some of the iV-acyl derivatives may be responsible for the diminished in vitro activities for the latter against Pseudomonasaeruginosa, as zwitterionic compoundsare known16) to penetrate the outer membrane F porin (OmpF) channels of these species faster than those with one or two negative charges. However, in the peptide derivatives the size, shape and the associated increase in hydrophobicity may contribute to their decreased in vitro activities against Pseudomonas aeruginosa.
à"In conclusion, it maybe suggested that while constructing a prodrug, it may be possible to utilize the auxiliary part in augmenting the action of the principal-drug-part, thus rendering the prodrug a "dual-action" drug.
Experimental
Solutions were evaporated below 30°C under diminished pressure. XH NMRspectra were recorded with a 6ruker-AC200SY instrument operating at 200 MHzor AMX400 operating at 400 MHzfor protons. Chemical shifts are expressed in ppm relative to TMS,sodium 3-trimethylsilylpropionate-2,2,3,3-J4 (TSP, for D2O samples) or to internal CDC13 (7.24), acetone-d6 (2.04), HOD(4.81). IR spectra were recorded on a Perkin-Elmer 781 instrument. UVspectra were recorded on a Hewlett Packard 8451Adiode array spectrometer. Solvents were reagent or spectrophotometric/chromatographic grade and used directly or dried over 4 A molecular sieves. THF was dried over sodium/Benzophenone and then distilled. Preparativê Bondapak C18 reverse-phase silica, 125A, 55~105^was obtained from Waters, Chromatography Division/Millipore Corporation.
General Procedure for the Preparation of N-Carboxy Anhydride1 7)
In a representative example, to a suspension of /?-chloro-L-alanine (1 g, 8.1 mmol) in dry THF (20ml) at 50°C, under an inert atmosphere, was added trichloromethylchloroformate. The clear solution was stirred for one hour at 50°C, solvent distilled off with water-aspirator at 30°C, ethyl acetate (20ml) was added to the residue and filtered. Hexane (80 ml) was added to the filtrate with stirring and the white solid was separated, washed with hexane (100ml) and dried in vacuum over P2O5 (0.88g, 73% General Procedure for the Preparation of Mono-and Dipeptide Derivatives of 4 and 5 In a typical example, 4 (0.44g, 1.35mmol) in 0.2m pH 7.0 buffer (NaH2PO4-Na2HPO4, 15ml) at 0°C was adjusted to pH 10.2 with I n NaOHand treated with 6 (0.16g, 1.35mmol) in dioxane (1.5ml) while bubbling argon through the solution. When the pH dropped to 7.2, it was readjusted to 10.2 and left there for one hour (Note: in most cases the reaction was finished in 30 minutes or less) to ensure complete reaction. Finally, the pH was adjusted to 6.0 and argon bubbling was continued for 30 minutes to ensure complete flushing of carbon dioxide. The reaction mixture was passed through a column (4.5 x 12.5 cm) of reverse-phase silica (juBondapak C18) packed in CH3CN and washed thoroughly with cold water. The crude product was eluted with water, lyophilized to a solid and then carefully rechromatographed on reverse-phase silica as above. Compounds 9 and 10 were eluted one after the other, in that order in all cases, with a mixture of water and CH3CN(93 : 7, gradient elution) and were obtained as white fluffy solids after lyophilization (9: 0.12g, 22.4%; 10: 0.065 g, 10.3%).
General Procedure for the Preparation of Mono-and Dipeptide Derivatives Using the Acylating Species 17
In a representative example, 4 (0.174g, 0.54mmol) in 0.2m pH 7.0 buffer (NaH2PO4-Na2HPO4, JAN. 1993 10ml) at 0°C was adjusted to pH 10.2 with 1n NaOH, under argon. This solution was added to a well stirred mixture containing equimolar quantities of 7 (0.062 g, 0.54 mmol) and DMAP(0.065 g, 0.54mmol) in dioxane (3ml) in a separate flask at 0°C while bubbling argon through the solution. Whenever the pH dropped, it was readjusted to 10.2 and left at 0°C for one hour to ensure complete reaction (Note: in someinstances it maybe necessary to leave the reaction at room temperature for an appropriate time). Finally, the pHwas adjusted to 6.0 and argon bubbling was continued for 30 minutes to ensure complete flushing of carbon dioxide. The reaction mixture was passed through a column (4.5 x 10 cm) of reverse-phase silica (^Bondapak C18) packed in CH3CNand washed thoroughly with cold water. The crude product was eluted with water, lyophilized to a solid and then carefully rechromatographed on reverse-phase silica, as above. Compoundll was eluted with a mixture of water and CH3CN(96 : 4, gradient elution) and was obtained as a white fluffy solid after lyophilization (0.065 g, 30.7%). Following the same procedure, the monopeptide 9 was converted into the dipeptide 10 in a yield of 30%.
Acid (9) Purity 92.9% by HPLC(UV detection at 300nm) on^Bondapak C18 column (4mm x 30cm), eluant: 3% CH3CNin pH 6.8 phosphate buffer, flow rate: 1 ml/minute, retention time: 5.57 minutes, UV Xmax 300nm. IR(nujol) 1750cm"1 (C=O, £-lactam).
XHNMR(200MHz, D2O 
Acid (10 
Acid (ll) The title compound was eluted with a mixture of water and CH3CN(97 : 3, gradient elution) and was obtained as a yellowish fluffy solid after lyophilization in 15.9% yield. Purity 96.5% by HPLC (UV detection at 300nm) on^Bondapak C18 column (4mm x 30cm), eluant: 5% CH3CNin pH 6.8 phosphate buffer, flow rate: 0.6ml/minute, retention time: 7.25 minutes, UV Amax 300nm. IR (nujol) 1750cm" 1 (C=O, 0-lactam 
Acid (12) The title compound was eluted with a mixture of water and CH3CN(96 :4, gradient elution) and was obtained as a yellowish fluffy solid after lyophilization in 9.4% yield. Purity 96.9% by HPLC (UV detection at 300nm) on^Bondapak C18 column (4mm x 30cm), eluant: 5% CH3CNin pH 6.8 phosphate buffer, flow rate: 0.6ml/minute, retention time: 9.1 minutes, UV Amax 300 nm. IR (nujol) 1750cm" 1 (C=O, 0-lactam 
Acid (14) The title compound was eluted with a mixture of water and CH3CN(94 : 6, gradient elution) and was obtained as a yellowish fluffy solid after lyophilization in 6.8% yield. Purity 92.2% by HPLC(UV detection at 300 nm) on //Bondapak C18 column (4mm x 30cm), eluant: 10% CH3CNin pH 6.8 phosphate buffer, flow rate: 1 ml/minute, retention time: 8.31 minutes, UV >lmax 300nm. IR (nujol) 1750cm"1 (OO, jS-lactam (4i?,55,65
Acid (15) The crude reaction mixture obtained from 0.15g, 0.42mmol of 5, was passed through a column (3.5 x 6 cm) of reverse-phase silica (/xBondapak C18). The crude title compound was eluted with a mixture of water and CH3CN(97 : 3, gradient elution) and was further purified by preparative HPLC using phosphate buffer as eluant. The desalting was effected by passing through reverse-phase silica (/xBondapak C18). The title compound was obtained as a white fluffy solid after lyophilization (0.02 g, 10.3%). Purity 99.7% by HPLC (UV detection at 300nm) on /xBondapak C18 column (4mmx 30cm), eluant: 10% CH3CN in pH 6.8 phosphate buffer, flow rate: 0.7 ml/minute, retention time: 7.47 minutes, UV Xmax 300 nm. IR (nujol) 1750cm-1 (C=O, jS-lactam).
*H NMR (200MHz, D2O) S: 1.35 (d, 3H, CH3, /=6.39Hz), 1.45-1.9 (overlap, 6H, (CH2)3), 2.83-3.37 (overlap, 7H, H-4, CH2CN, SCH2, CH2NH), 3.42 (dd, 1H, H-6, /5,6=2.49Hz, /6,r=5.93Hz), 3.85 (centre ofm, 3H, CaH, C^H2), 4.25 (dd, overlap, 1H, H-5), 4.29 (m, 1H,' H-l' ) .
A solution of (4i?,5S,6S)-6-[l^)-l'-hydroxyethyl]-3-(2-cyanâ zabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid 4 (0.26g, 0.8mmol) in 0.1 m pH 7.0 sodium-phosphate buffer (10ml) was cooled to 0°C and dioxane (10ml) was added. Acetyl chloride (0.19 g, 0.17ml, 2.4mmol) was added and the pH was adjusted to 9 with 1 n NaOH, when it dropped to 2.3. After an hour acetic anhydride (0.245g, 0.23ml, 2.4mmol) was added to ensure complete iV-acetylation and the pH was readjusted to 8 and left there for one hour. The reaction mixture was passed through a column of//Bondapak C18 reverse-phase silica (4.5 x ll cm) packed in CH3CNand washed thoroughly with cold water. Appropriate fractions belonging to the product were eluted with water, combined and lyophilized to a solid which was rechromatographed on reverse-phase silica, as above. The title compoundwas eluted with water and was obtained as a white fluffy solid after lyophilization (0.07 g, 22.6%). Purity 99.5% by HPLC (UV detection at 300nm) on jiBondapak C18 column (4mm x 30cm), eluant: pH 7.0 phosphate buffer, flow rate: 1.5ml/minute, retention time: 10.66minutes, UV Amax 300nm. IR (nujol) 1750cm"1 (C=O, £-lactam 2-Azidopropionyl Chloride Chloropropionic acid (10 g, 0.092 mol) in water (10 ml) was stirred until a clear solution was obtained, and then 3.45ml of a 2m NaOHsolution was added dropwise over a period of 15 minutes. A slurry of sodium azide (15.6g, 0.24mol) in water (20ml) was added portionwise to this mixture and stirred until a clear solution was obtained, adding more water (6 ml) if needed. Ether (50 ml) was added and the mixture was gently refluxed at 65°C for 24 hours and at 75°C for additional 24 hours, with stirring. The reaction mixture was cooled in ice-water bath and cone H2SO4 (4.42ml in 16.5ml of water) was added dropwise over a period of one hour. The pH of the aqueous phase was adjusted from 6 to 1 by careful addition of cone H2SO4.Sodiumchloride was added and the ether layer was decanted from the voluminous solid/gel. More ether (50 ml) was added, stirred and decanted. The process was repeated once more. The combined ether solution was dried over anhydrous Na2SO4,and the solvent was removed in vacuo to give a syrup which was finally rotary evaporated 3 times with 100ml portions of CH2C12to remove residual ether and the hazardous HN3 to give 2-azidopropionic acid (10.7 g). IR (neat) 2100cm" 1 (N3). XH NMR(200 MHz, CDC13) d: 2.62 (t, 2H, CH2CO, /=6.42Hz), 3.57 (t, 2H, N3CH2) . The above acid (10.7 g, 0.093 mol) was treated dropwise, under argon, with thionyl chloride (22.13 g, 13.57ml, 0.186mol) over a period of 15minutes. After gas evolution abated, the mixture was heated at 55°C for 2 hours, and fractionally distilled.
The fraction boiling in the range 76-82°C at 28mmHgwas collected.
IR (neat) 1790cm-1 (COC1), 2100cm"1 (N3). XH NMR (200MHz, CDC13) 6: 3.ll (t, 2H, CH2CO, /=6.2Hz), 3.61 (t, 2H, N3CH2) .
0)-hept-2-ene-2-carboxylate (23) A solution of 4 (0.26g, 0.8mmol) in 0.2m pH 7.0 sodium phosphate buffer (20ml) at 0°C was diluted with dioxane (20ml) and the pH was adjusted to 8.5 with 1 n NaOH. 2-Azidopropionylchloride (0.215 g, 1.61 mmol) in dioxane (2ml) was added, the pH was readjusted to 8.5 and maintained there for one hour after which it was adjusted to 7.0 with 1 n HC1. The crude reaction mixture was passed through a column (4.5 x 1 1 cm) of reverse-phase silica (^Bondapak C18) packed in CH3CNand washed thoroughly with cold water. Eluted with water and the fractions belonging to the product were combined and lyophilized to a solid which was rechromatographed on reverse-phase silica, as above. The title compoundwas eluted with a mixture of water and CH3CN(96 : 4, gradient elution) and was obtained as a white fluffy solid after lyophilization (0.194g, 54.3% (4i?, 55f,65
Acid (19) A solution of 23 (0.165g, 0.37mmol) in a 0.1m pH 7.0 sodium phosphate buffer (20ml) was hydrogenated at 0°C over 5% palladium on alumina (1 g) at 3.164kg/cm2 for one hour. The catalyst was filtered, washed with water, the pH of the filtrate was adjusted to 6.8 with 1 m NaH2PO4and passed through a column (4.5 x ll cm) of reverse-phase silica (/xBondapak C18). Two compounds were eluted from the column of which the less polar title compoundwas eluted with a mixture of water and CH3CN (96 : 4, gradient elution) and was obtained as a white fluffy solid after lyophilization (0.05 g, 34%). Purity 95.3% by HPLC (UV detection at 300nm) on /iBondapak C18 column (4mm x 30cm), eluant: 8% CH3CN in pH 5.8 phosphate buffer, flow rate: 0.5ml/minute, retention time: 8.9 minutes, UVAmax 300nm. IR (nujol) 1750cm"1 (C=O, jft-lactam 7-oxo-l -azabicyclo(3.2.0)-hept-2-ene-2-carboxylate (22) A solution of4 (0.26g, 0.8mmol) in 0.2m pH 7.0 sodium-phosphate buffer (20ml) at 0°C was diluted with dioxane (20ml) and the pH was adjusted to 8.5 with In NaOH. Azidoacetyl chloride18) (0.3g, 2.5mmol) in dioxane (2ml) was added, the pH was readjusted to 8.0 and maintained there for one hour after which it was adjusted to 7.0 with 1 n HC1. The crude reaction mixture was passed through a column (4.5 x 12 cm) of reverse-phase silica (/iBondapak C18) packed in CH3CNand washed thoroughly with cold water. Eluted with water and the fractions belonging to the product were combined and lyophilized to a solid which was rechromatographed on reverse-phase silica, as above. The title compoundwas eluted with a mixture of water and CH3CN(98 :2, gradient elution) and was obtained as a white fluffy solid after lyophilization (0.12g, 35% 
